Cypros Pharmaceutical Reports Data From Phase II Trial of Ceresine in Stroke Patients; Results Confirm Those Found in Earlier Traumatic Brain Injury Trial.
Business Wire › February 18, 1999
Linked as:
Extract
Cypros Pharmaceutical Reports Data From Phase II Trial of Ceresine in Stroke Patients; Results Confirm Those Found in Earlier Traumatic Brain Injury Trial.
CARLSBAD, Calif.--(BW HealthWire)--Feb. 18, 1999--Cypros Pharmaceutical Corp. (AMEX:CYP) announced today that the results of its placebo-con...
See the full content of this document
Sponsored links
